EcoDrugPlus

Platelet Derived Growth Factor Receptor, Alpha Polypeptide

Ensembl ID : ENSMSIG00000019363
Gene Symbol: PDGFRA
1 Cross references
219 Possible Orthologues:

Platelet Derived Growth Factor Receptor, Beta Polypeptide

Ensembl ID : ENSMSIG00000002120
Gene Symbol: PDGFRB
1 Cross references
262 Possible Orthologues:

Platelet Derived Growth Factor, B Polypeptide

Ensembl ID : ENSMSIG00000028914
Gene Symbol: PDGFB
1 Cross references
276 Possible Orthologues:

Platelet-Activating Factor Receptor

Ensembl ID : ENSMSIG00000008840
Gene Symbol: PTAFR
1 Cross references
239 Possible Orthologues:

Polo Like Kinase 1

Ensembl ID : ENSMSIG00000028255
Gene Symbol: PLK1
1 Cross references
197 Possible Orthologues:

Polo Like Kinase 4

Ensembl ID : ENSMSIG00000009066
Gene Symbol: PLK4
1 Cross references
223 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 1

Ensembl ID : ENSMSIG00000007405
Gene Symbol: PARP1
1 Cross references
224 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 2

Ensembl ID : ENSMSIG00000019262
Gene Symbol: PARP2
1 Cross references
200 Possible Orthologues:

Poly (Adp-Ribose) Polymerase Family, Member 3

Ensembl ID : ENSMSIG00000010391
Gene Symbol: PARP3
1 Cross references
214 Possible Orthologues:

Porcupine O-Acyltransferase

Ensembl ID : ENSMSIG00000022361
Gene Symbol: PORCN
1 Cross references
278 Possible Orthologues:

Potassium Channel, Subfamily K, Member 2

Ensembl ID : ENSMSIG00000029469
Gene Symbol: KCNK2
1 Cross references
295 Possible Orthologues:

Potassium Channel, Subfamily K, Member 3

Ensembl ID : ENSMSIG00000013471
Gene Symbol: KCNK3
1 Cross references
218 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).